Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 492

1.

Increasing access to integrated ESKD care as part of universal health coverage.

Harris DCH, Davies SJ, Finkelstein FO, Jha V, Donner JA, Abraham G, Bello AK, Caskey FJ, Garcia GG, Harden P, Hemmelgarn B, Johnson DW, Levin NW, Luyckx VA, Martin DE, McCulloch MI, Moosa MR, O'Connell PJ, Okpechi IG, Pecoits Filho R, Shah KD, Sola L, Swanepoel C, Tonelli M, Twahir A, van Biesen W, Varghese C, Yang CW, Zuniga C; Working Groups of the International Society of Nephrology’s 2nd Global Kidney Health Summit.

Kidney Int. 2019 Apr;95(4S):S1-S33. doi: 10.1016/j.kint.2018.12.005. Review.

PMID:
30904051
2.

Red cell distribution width associations with clinical outcomes: A population-based cohort study.

Tonelli M, Wiebe N, James MT, Naugler C, Manns BJ, Klarenbach SW, Hemmelgarn BR.

PLoS One. 2019 Mar 13;14(3):e0212374. doi: 10.1371/journal.pone.0212374. eCollection 2019.

3.

Nephrology consultation and mortality in people with stage 4 chronic kidney disease: a population-based study.

Liu P, Quinn RR, Karim ME, Bello A, Tam-Tham H, Weaver R, Ronksley PE, Quan H, Strippoli GFM, Manns B, Hemmelgarn BR, Tonelli M, Ravani P.

CMAJ. 2019 Mar 11;191(10):E274-E282. doi: 10.1503/cmaj.181372.

4.

Outcomes Following Macrolide Use in Kidney Transplant Recipients.

Jeong R, Quinn RR, Lentine KL, Lloyd A, Ravani P, Hemmelgarn B, Braam B, Garg AX, Wen K, Wong-Chan A, Gourishankar S, Lam NN.

Can J Kidney Health Dis. 2019 Feb 21;6:2054358119830706. doi: 10.1177/2054358119830706. eCollection 2019.

5.

The association between payment model and specialist physicians' selection of patients with diabetes: a descriptive study.

Quinn AE, Edwards A, Senior P, McBrien KA, Hemmelgarn BR, Tonelli M, Au F, Ma Z, Weaver RG, Manns BJ.

CMAJ Open. 2019 Feb 18;7(1):E109-E116. doi: 10.9778/cmajo.20180171. Print 2019 Jan-Mar.

6.

Comparison of the Complexity of Patients Seen by Different Medical Subspecialists in a Universal Health Care System.

Tonelli M, Wiebe N, Manns BJ, Klarenbach SW, James MT, Ravani P, Pannu N, Himmelfarb J, Hemmelgarn BR.

JAMA Netw Open. 2018 Nov 2;1(7):e184852. doi: 10.1001/jamanetworkopen.2018.4852.

7.

Change in Proteinuria or Albuminuria as a Surrogate for Cardiovascular and Other Major Clinical Outcomes: A Systematic Review and Meta-analysis.

Harrison TG, Tam-Tham H, Hemmelgarn BR, Elliott M, James MT, Ronksley PE, Jun M.

Can J Cardiol. 2019 Jan;35(1):77-91. doi: 10.1016/j.cjca.2018.10.014. Epub 2018 Oct 29. Review.

PMID:
30595186
8.

Effectiveness and components of self-management interventions in adult cancer survivors: a protocol for a systematic review and planned meta-analysis.

Cuthbert CA, Samawi HH, Hemmelgarn BR, Cheung WY.

Syst Rev. 2018 Dec 20;7(1):238. doi: 10.1186/s13643-018-0902-7.

9.

Exploring structural barriers to diabetes self-management in Alberta First Nations communities.

Kulhawy-Wibe S, King-Shier KM, Barnabe C, Manns BJ, Hemmelgarn BR, Campbell DJT.

Diabetol Metab Syndr. 2018 Dec 3;10:87. doi: 10.1186/s13098-018-0385-7. eCollection 2018.

10.

Renal Function, Albuminuria, and the Risk of Cardiovascular Events After Kidney Transplantation.

Lam NN, Klarenbach S, Quinn RR, Hemmelgarn B, Tonelli M, Ye F, Ravani P, Bello AK, Brennan DC, Lentine KL.

Transplant Direct. 2018 Sep 6;4(10):e389. doi: 10.1097/TXD.0000000000000828. eCollection 2018 Oct.

11.

Identification and Prioritization of Quality Indicators for Conservative Kidney Management.

Harrison TG, Tam-Tham H, Hemmelgarn BR, James MT, Sinnarajah A, Thomas CM.

Am J Kidney Dis. 2019 Feb;73(2):174-183. doi: 10.1053/j.ajkd.2018.08.014. Epub 2018 Oct 25.

PMID:
30482578
12.

Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With Outcomes After Acute Kidney Injury.

Brar S, Ye F, James MT, Hemmelgarn B, Klarenbach S, Pannu N; Interdisciplinary Chronic Disease Collaboration .

JAMA Intern Med. 2018 Dec 1;178(12):1681-1690. doi: 10.1001/jamainternmed.2018.4749.

PMID:
30422153
13.

Perceived Significance of Engagement in Research Prioritization Among Chronic Kidney Disease Patients, Caregivers, and Health Care Professionals: A Qualitative Study.

Elliott MJ, Goodarzi Z, Sale JEM, Wilhelm LA, Laupacis A, Hemmelgarn BR, Straus SE.

Can J Kidney Health Dis. 2018 Oct 19;5:2054358118807480. doi: 10.1177/2054358118807480. eCollection 2018.

14.

Implementing core outcomes in kidney disease: report of the Standardized Outcomes in Nephrology (SONG) implementation workshop.

Tong A, Manns B, Wang AYM, Hemmelgarn B, Wheeler DC, Gill J, Tugwell P, Pecoits-Filho R, Crowe S, Harris T, Van Biesen W, Winkelmayer WC, Levin A, Thompson A, Perkovic V, Ju A, Gutman T, Bernier-Jean A, Viecelli AK, O'Lone E, Shen J, Josephson MA, Cho Y, Johnson DW, Sautenet B, Tonelli M, Craig JC; SONG Implementation Workshop Investigators.

Kidney Int. 2018 Dec;94(6):1053-1068. doi: 10.1016/j.kint.2018.08.018. Epub 2018 Oct 22.

PMID:
30360959
15.

Pharmacist prescribing and care improves cardiovascular risk, but what do patients think? A substudy of the RxEACH study.

Al Harmarneh YN, Lamb S, Donald M, Hemmelgarn B, King Shier K, Jones CA, Mitchell C, Tsuyuki RT.

Can Pharm J (Ott). 2018 May 30;151(4):223-227. doi: 10.1177/1715163518779092. eCollection 2018 Jul-Aug. No abstract available.

16.

Sustaining knowledge translation interventions for chronic disease management in older adults: protocol for a systematic review and network meta-analysis.

Tricco AC, Moore JE, Beben N, Brownson RC, Chambers DA, Dolovich LR, Edwards A, Fairclough L, Glasziou PP, Graham ID, Hemmelgarn BR, Holmes B, Isaranuwatchai W, Lachance CC, Legare F, McGowan J, Majumdar SR, Presseau J, Squires JE, Stelfox HT, Strifler L, Thompson K, Van der Weijden T, Veroniki AA, Straus SE.

Syst Rev. 2018 Sep 15;7(1):140. doi: 10.1186/s13643-018-0808-4.

17.

The effect of comorbidities on outcomes in colorectal cancer survivors: a population-based cohort study.

Cuthbert CA, Hemmelgarn BR, Xu Y, Cheung WY.

J Cancer Surviv. 2018 Dec;12(6):733-743. doi: 10.1007/s11764-018-0710-z. Epub 2018 Sep 6.

PMID:
30191524
18.

Long-term views on chronic kidney disease research priorities among stakeholders engaged in a priority-setting partnership: A qualitative study.

Elliott MJ, Sale JEM, Goodarzi Z, Wilhelm L, Laupacis A, Hemmelgarn BR, Straus SE.

Health Expect. 2018 Dec;21(6):1142-1149. doi: 10.1111/hex.12818. Epub 2018 Aug 15.

19.

Follow-up Care of Living Kidney Donors in Alberta, Canada.

Lam NN, Lentine KL, Hemmelgarn B, Klarenbach S, Quinn RR, Lloyd A, Gourishankar S, Garg AX.

Can J Kidney Health Dis. 2018 Jul 26;5:2054358118789366. doi: 10.1177/2054358118789366. eCollection 2018.

20.

Enhancing the uptake of systematic reviews of effects: what is the best format for health care managers and policy-makers? A mixed-methods study.

Marquez C, Johnson AM, Jassemi S, Park J, Moore JE, Blaine C, Bourdon G, Chignell M, Ellen ME, Fortin J, Graham ID, Hayes A, Hamid J, Hemmelgarn B, Hillmer M, Holmes B, Holroyd-Leduc J, Hubert L, Hutton B, Kastner M, Lavis JN, Michell K, Moher D, Ouimet M, Perrier L, Proctor A, Noseworthy T, Schuckel V, Stayberg S, Tonelli M, Tricco AC, Straus SE.

Implement Sci. 2018 Jun 22;13(1):84. doi: 10.1186/s13012-018-0779-9. Review.

21.

Comparative safety and effectiveness of perinatal antiretroviral therapies for HIV-infected women and their children: Systematic review and network meta-analysis including different study designs.

Veroniki AA, Antony J, Straus SE, Ashoor HM, Finkelstein Y, Khan PA, Ghassemi M, Blondal E, Ivory JD, Hutton B, Gough K, Hemmelgarn BR, Lillie E, Vafaei A, Tricco AC.

PLoS One. 2018 Jun 18;13(6):e0198447. doi: 10.1371/journal.pone.0198447. eCollection 2018.

22.

Effectiveness, Complications, and Costs of Rheumatoid Arthritis Treatment with Biologics in Alberta: Experience of Indigenous and Non-indigenous Patients.

Barnabe C, Zheng Y, Ohinmaa A, Crane L, White T, Hemmelgarn B, Kaplan GG, Martin L, Maksymowych WP.

J Rheumatol. 2018 Oct;45(10):1344-1352. doi: 10.3899/jrheum.170779. Epub 2018 Jun 1.

PMID:
29858236
23.

Risk Factors for Prognosis in Patients With Severely Decreased GFR.

Evans M, Grams ME, Sang Y, Astor BC, Blankestijn PJ, Brunskill NJ, Collins JF, Kalra PA, Kovesdy CP, Levin A, Mark PB, Moranne O, Rao P, Rios PG, Schneider MP, Shalev V, Zhang H, Chang AR, Gansevoort RT, Matsushita K, Zhang L, Eckardt KU, Hemmelgarn B, Wheeler DC.

Kidney Int Rep. 2018 Jan 11;3(3):625-637. doi: 10.1016/j.ekir.2018.01.002. eCollection 2018 May. Erratum in: Kidney Int Rep. 2018 Aug 30;3(6):1506.

24.

Overview of Self-Management Resources Used by Canadian Chronic Kidney Disease Clinics: A National Survey.

Donald M, Gil S, Kahlon B, Beanlands H, Straus S, Herrington G, Manns B, Hemmelgarn BR.

Can J Kidney Health Dis. 2018 May 22;5:2054358118775098. doi: 10.1177/2054358118775098. eCollection 2018.

25.

Survival among older adults with kidney failure is better in the first three years with chronic dialysis treatment than not.

Tam-Tham H, Quinn RR, Weaver RG, Zhang J, Ravani P, Liu P, Thomas C, King-Shier K, Fruetel K, James MT, Manns BJ, Tonelli M, Murtagh FEM, Hemmelgarn BR.

Kidney Int. 2018 Sep;94(3):582-588. doi: 10.1016/j.kint.2018.03.007. Epub 2018 May 24.

PMID:
29803405
26.

Clinicians' and researchers' perspectives on establishing and implementing core outcomes in haemodialysis: semistructured interview study.

Tong A, Crowe S, Gill JS, Harris T, Hemmelgarn BR, Manns B, Pecoits-Filho R, Tugwell P, van Biesen W, Wang AYM, Wheeler DC, Winkelmayer WC, Gutman T, Ju A, O'Lone E, Sautenet B, Viecelli A, Craig JC.

BMJ Open. 2018 Apr 20;8(4):e021198. doi: 10.1136/bmjopen-2017-021198.

27.

Improving the prognosis of patients with severely decreased glomerular filtration rate (CKD G4+): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Eckardt KU, Bansal N, Coresh J, Evans M, Grams ME, Herzog CA, James MT, Heerspink HJL, Pollock CA, Stevens PE, Tamura MK, Tonelli MA, Wheeler DC, Winkelmayer WC, Cheung M, Hemmelgarn BR; Conference Participants.

Kidney Int. 2018 Jun;93(6):1281-1292. doi: 10.1016/j.kint.2018.02.006. Epub 2018 Apr 12.

28.

Perceived Benefits and Challenges of a Risk-Based Approach to Multidisciplinary Chronic Kidney Disease Care: A Qualitative Descriptive Study.

Smekal MD, Tam-Tham H, Finlay J, Donald M, Benterud E, Thomas C, Quinn RR, Tam K, Manns BJ, Tonelli M, Bello A, Tangri N, Hemmelgarn BR.

Can J Kidney Health Dis. 2018 Mar 23;5:2054358118763809. doi: 10.1177/2054358118763809. eCollection 2018.

29.

Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rate.

Grams ME, Sang Y, Ballew SH, Carrero JJ, Djurdjev O, Heerspink HJL, Ho K, Ito S, Marks A, Naimark D, Nash DM, Navaneethan SD, Sarnak M, Stengel B, Visseren FLJ, Wang AY, Köttgen A, Levey AS, Woodward M, Eckardt KU, Hemmelgarn B, Coresh J.

Kidney Int. 2018 Jun;93(6):1442-1451. doi: 10.1016/j.kint.2018.01.009. Epub 2018 Mar 29. Erratum in: Kidney Int. 2018 Nov;94(5):1025-1026.

PMID:
29605094
30.

Concentrations of Trace Elements and Clinical Outcomes in Hemodialysis Patients: A Prospective Cohort Study.

Tonelli M, Wiebe N, Bello A, Field CJ, Gill JS, Hemmelgarn BR, Holmes DT, Jindal K, Klarenbach SW, Manns BJ, Thadhani R, Kinniburgh D; Alberta Kidney Disease Network.

Clin J Am Soc Nephrol. 2018 Jun 7;13(6):907-915. doi: 10.2215/CJN.11451017. Epub 2018 Mar 29.

PMID:
29599300
31.

Self-management interventions for adults with chronic kidney disease: a scoping review.

Donald M, Kahlon BK, Beanlands H, Straus S, Ronksley P, Herrington G, Tong A, Grill A, Waldvogel B, Large CA, Large CL, Harwood L, Novak M, James MT, Elliott M, Fernandez N, Brimble S, Samuel S, Hemmelgarn BR.

BMJ Open. 2018 Mar 22;8(3):e019814. doi: 10.1136/bmjopen-2017-019814. Review.

32.

A population-based cohort study defines prognoses in severe chronic kidney disease.

Tonelli M, Wiebe N, James MT, Klarenbach SW, Manns BJ, Ravani P, Strippoli GFM, Hemmelgarn BR; Alberta Kidney Disease Network.

Kidney Int. 2018 May;93(5):1217-1226. doi: 10.1016/j.kint.2017.12.013. Epub 2018 Mar 7.

PMID:
29525394
33.

Association between Duration of Predialysis Care and Mortality after Dialysis Start.

Liu P, Quinn RR, Oliver MJ, Ronksley PE, Hemmelgarn BR, Quan H, Hiremath S, Bello AK, Blake PG, Garg AX, Johnson J, Verrelli M, Zacharias JM, Abd ElHafeez S, Tonelli M, Ravani P.

Clin J Am Soc Nephrol. 2018 Jun 7;13(6):893-899. doi: 10.2215/CJN.11951017. Epub 2018 Mar 5.

PMID:
29507006
34.

Scope and Consistency of Outcomes Reported in Randomized Trials Conducted in Adults Receiving Hemodialysis: A Systematic Review.

Sautenet B, Tong A, Williams G, Hemmelgarn BR, Manns B, Wheeler DC, Tugwell P, van Biesen W, Winkelmayer WC, Crowe S, Harris T, Evangelidis N, Hawley CM, Pollock C, Johnson DW, Polkinghorne KR, Howard K, Gallagher MP, Kerr PG, McDonald SP, Ju A, Craig JC.

Am J Kidney Dis. 2018 Jul;72(1):62-74. doi: 10.1053/j.ajkd.2017.11.010. Epub 2018 Feb 21.

PMID:
29475768
35.

Reproducibility of clinical research in critical care: a scoping review.

Niven DJ, McCormick TJ, Straus SE, Hemmelgarn BR, Jeffs L, Barnes TRM, Stelfox HT.

BMC Med. 2018 Feb 21;16(1):26. doi: 10.1186/s12916-018-1018-6. Review.

36.

Patient navigators for people with chronic disease: A systematic review.

McBrien KA, Ivers N, Barnieh L, Bailey JJ, Lorenzetti DL, Nicholas D, Tonelli M, Hemmelgarn B, Lewanczuk R, Edwards A, Braun T, Manns B.

PLoS One. 2018 Feb 20;13(2):e0191980. doi: 10.1371/journal.pone.0191980. eCollection 2018. Review.

37.

Patient-reported Outcomes, Resource Use, and Social Participation of Patients with Rheumatoid Arthritis Treated with Biologics in Alberta: Experience of Indigenous and Non-indigenous Patients.

Barnabe C, Crane L, White T, Hemmelgarn B, Kaplan GG, Martin L, Maksymowych WP.

J Rheumatol. 2018 Jun;45(6):760-765. doi: 10.3899/jrheum.170778. Epub 2018 Feb 15.

PMID:
29449496
38.
39.

Implementation and Evaluation of a Risk-Based Approach to Guide Chronic Kidney Disease Care: Protocol for a Multiphase Mixed-Methods Study.

Hemmelgarn BR, Smekal MD, Weaver RG, Thomas C, Benterud E, Tam K, Manns BJ, Tonelli M, Finlay J, Donald M, Tam-Tham H, Bello A, Tangri N, Quinn RR.

Can J Kidney Health Dis. 2018 Jan 17;5:2054358117753618. doi: 10.1177/2054358117753618. eCollection 2018.

40.

Canadians Seeking Solutions and Innovations to Overcome Chronic Kidney Disease (Can-SOLVE CKD): Form and Function.

Levin A, Adams E, Barrett BJ, Beanlands H, Burns KD, Chiu HH, Chong K, Dart A, Ferera J, Fernandez N, Fowler E, Garg AX, Gilbert R, Harris H, Harvey R, Hemmelgarn B, James M, Johnson J, Kappel J, Komenda P, McCormick M, McIntyre C, Mahmud F, Pei Y, Pollock G, Reich H, Rosenblum ND, Scholey J, Sochett E, Tang M, Tangri N, Tonelli M, Turner C, Walsh M, Woods C, Manns B.

Can J Kidney Health Dis. 2018 Jan 17;5:2054358117749530. doi: 10.1177/2054358117749530. eCollection 2018.

41.

Proportion of women presenters at medical grand rounds at major academic centres in Canada: a retrospective observational study.

Buell D, Hemmelgarn BR, Straus SE.

BMJ Open. 2018 Jan 18;8(1):e019796. doi: 10.1136/bmjopen-2017-019796.

42.

Effectiveness and Cost of Weekly Recombinant Tissue Plasminogen Activator Hemodialysis Catheter Locking Solution.

Hemmelgarn BR, Manns BJ, Soroka SD, Levin A, MacRae J, Tennankore K, Wilson JS, Weaver RG, Ravani P, Quinn RR, Tonelli M, Kiaii M, Mossop P, Scott-Douglas N.

Clin J Am Soc Nephrol. 2018 Mar 7;13(3):429-435. doi: 10.2215/CJN.08510817. Epub 2018 Jan 15.

43.

Health care costs associated with hospital acquired complications in patients with chronic kidney disease.

Bohlouli B, Jackson T, Tonelli M, Hemmelgarn B, Klarenbach S.

BMC Nephrol. 2017 Dec 28;18(1):375. doi: 10.1186/s12882-017-0784-2.

44.

Catheter-related blood stream infections in hemodialysis patients: a prospective cohort study.

Thompson S, Wiebe N, Klarenbach S, Pelletier R, Hemmelgarn BR, Gill JS, Manns BJ, Tonelli M; Alberta Kidney Disease Network.

BMC Nephrol. 2017 Dec 8;18(1):357. doi: 10.1186/s12882-017-0773-5.

45.

Derivation and External Validation of Prediction Models for Advanced Chronic Kidney Disease Following Acute Kidney Injury.

James MT, Pannu N, Hemmelgarn BR, Austin PC, Tan Z, McArthur E, Manns BJ, Tonelli M, Wald R, Quinn RR, Ravani P, Garg AX.

JAMA. 2017 Nov 14;318(18):1787-1797. doi: 10.1001/jama.2017.16326.

46.

Comparative Effectiveness and Safety of Cognitive Enhancers for Treating Alzheimer's Disease: Systematic Review and Network Metaanalysis.

Tricco AC, Ashoor HM, Soobiah C, Rios P, Veroniki AA, Hamid JS, Ivory JD, Khan PA, Yazdi F, Ghassemi M, Blondal E, Ho JM, Ng CH, Hemmelgarn B, Majumdar SR, Perrier L, Straus SE.

J Am Geriatr Soc. 2018 Jan;66(1):170-178. doi: 10.1111/jgs.15069. Epub 2017 Sep 29.

PMID:
29131306
47.

Health Care Costs Associated with AKI.

Collister D, Pannu N, Ye F, James M, Hemmelgarn B, Chui B, Manns B, Klarenbach S; Alberta Kidney Disease Network.

Clin J Am Soc Nephrol. 2017 Nov 7;12(11):1733-1743. doi: 10.2215/CJN.00950117. Epub 2017 Oct 19.

48.

Comparative safety of direct oral anticoagulants and warfarin in venous thromboembolism: multicentre, population based, observational study.

Jun M, Lix LM, Durand M, Dahl M, Paterson JM, Dormuth CR, Ernst P, Yao S, Renoux C, Tamim H, Wu C, Mahmud SM, Hemmelgarn BR; Canadian Network for Observational Drug Effect Studies (CNODES) Investigators.

BMJ. 2017 Oct 17;359:j4323. doi: 10.1136/bmj.j4323.

49.

Disparity between Nephrologists' Opinions and Contemporary Practices for Community Follow-Up after AKI Hospitalization.

Karsanji DJ, Pannu N, Manns BJ, Hemmelgarn BR, Tan Z, Jindal K, Scott-Douglas N, James MT.

Clin J Am Soc Nephrol. 2017 Nov 7;12(11):1753-1761. doi: 10.2215/CJN.01450217. Epub 2017 Oct 12.

50.

The Effectiveness of Pharmacist Interventions on Cardiovascular Risk in Adult Patients with Type 2 Diabetes: The Multicentre Randomized Controlled RxEACH Trial.

Al Hamarneh YN, Hemmelgarn BR, Hassan I, Jones CA, Tsuyuki RT.

Can J Diabetes. 2017 Dec;41(6):580-586. doi: 10.1016/j.jcjd.2017.08.244. Epub 2017 Sep 28.

PMID:
28965748

Supplemental Content

Loading ...
Support Center